John Hwa, MD, PhD

Yale University
Population Pharmacology

Dr. Hwa's expertise is in the pharmacogenetics of G-protein coupled receptors, the targets of many cyclooxygenase (COX)-1 and COX-2 products. His focus is on cardiovascular disease and side effects in both clinical studies and translational studies. More recently his laboratory has also been exploring the effects of prostanoids on platelet function and dysfunction, both in human and mouse models.